Cargando…
Human Brain Organoids-on-Chip: Advances, Challenges, and Perspectives for Preclinical Applications
There is an urgent need for predictive in vitro models to improve disease modeling and drug target identification and validation, especially for neurological disorders. Cerebral organoids, as alternative methods to in vivo studies, appear now as powerful tools to decipher complex biological processe...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9699341/ https://www.ncbi.nlm.nih.gov/pubmed/36365119 http://dx.doi.org/10.3390/pharmaceutics14112301 |
_version_ | 1784839048734441472 |
---|---|
author | Castiglione, Héloïse Vigneron, Pierre-Antoine Baquerre, Camille Yates, Frank Rontard, Jessica Honegger, Thibault |
author_facet | Castiglione, Héloïse Vigneron, Pierre-Antoine Baquerre, Camille Yates, Frank Rontard, Jessica Honegger, Thibault |
author_sort | Castiglione, Héloïse |
collection | PubMed |
description | There is an urgent need for predictive in vitro models to improve disease modeling and drug target identification and validation, especially for neurological disorders. Cerebral organoids, as alternative methods to in vivo studies, appear now as powerful tools to decipher complex biological processes thanks to their ability to recapitulate many features of the human brain. Combining these innovative models with microfluidic technologies, referred to as brain organoids-on-chips, allows us to model the microenvironment of several neuronal cell types in 3D. Thus, this platform opens new avenues to create a relevant in vitro approach for preclinical applications in neuroscience. The transfer to the pharmaceutical industry in drug discovery stages and the adoption of this approach by the scientific community requires the proposition of innovative microphysiological systems allowing the generation of reproducible cerebral organoids of high quality in terms of structural and functional maturation, and compatibility with automation processes and high-throughput screening. In this review, we will focus on the promising advantages of cerebral organoids for disease modeling and how their combination with microfluidic systems can enhance the reproducibility and quality of these in vitro models. Then, we will finish by explaining why brain organoids-on-chips could be considered promising platforms for pharmacological applications. |
format | Online Article Text |
id | pubmed-9699341 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-96993412022-11-26 Human Brain Organoids-on-Chip: Advances, Challenges, and Perspectives for Preclinical Applications Castiglione, Héloïse Vigneron, Pierre-Antoine Baquerre, Camille Yates, Frank Rontard, Jessica Honegger, Thibault Pharmaceutics Review There is an urgent need for predictive in vitro models to improve disease modeling and drug target identification and validation, especially for neurological disorders. Cerebral organoids, as alternative methods to in vivo studies, appear now as powerful tools to decipher complex biological processes thanks to their ability to recapitulate many features of the human brain. Combining these innovative models with microfluidic technologies, referred to as brain organoids-on-chips, allows us to model the microenvironment of several neuronal cell types in 3D. Thus, this platform opens new avenues to create a relevant in vitro approach for preclinical applications in neuroscience. The transfer to the pharmaceutical industry in drug discovery stages and the adoption of this approach by the scientific community requires the proposition of innovative microphysiological systems allowing the generation of reproducible cerebral organoids of high quality in terms of structural and functional maturation, and compatibility with automation processes and high-throughput screening. In this review, we will focus on the promising advantages of cerebral organoids for disease modeling and how their combination with microfluidic systems can enhance the reproducibility and quality of these in vitro models. Then, we will finish by explaining why brain organoids-on-chips could be considered promising platforms for pharmacological applications. MDPI 2022-10-26 /pmc/articles/PMC9699341/ /pubmed/36365119 http://dx.doi.org/10.3390/pharmaceutics14112301 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Castiglione, Héloïse Vigneron, Pierre-Antoine Baquerre, Camille Yates, Frank Rontard, Jessica Honegger, Thibault Human Brain Organoids-on-Chip: Advances, Challenges, and Perspectives for Preclinical Applications |
title | Human Brain Organoids-on-Chip: Advances, Challenges, and Perspectives for Preclinical Applications |
title_full | Human Brain Organoids-on-Chip: Advances, Challenges, and Perspectives for Preclinical Applications |
title_fullStr | Human Brain Organoids-on-Chip: Advances, Challenges, and Perspectives for Preclinical Applications |
title_full_unstemmed | Human Brain Organoids-on-Chip: Advances, Challenges, and Perspectives for Preclinical Applications |
title_short | Human Brain Organoids-on-Chip: Advances, Challenges, and Perspectives for Preclinical Applications |
title_sort | human brain organoids-on-chip: advances, challenges, and perspectives for preclinical applications |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9699341/ https://www.ncbi.nlm.nih.gov/pubmed/36365119 http://dx.doi.org/10.3390/pharmaceutics14112301 |
work_keys_str_mv | AT castiglioneheloise humanbrainorganoidsonchipadvanceschallengesandperspectivesforpreclinicalapplications AT vigneronpierreantoine humanbrainorganoidsonchipadvanceschallengesandperspectivesforpreclinicalapplications AT baquerrecamille humanbrainorganoidsonchipadvanceschallengesandperspectivesforpreclinicalapplications AT yatesfrank humanbrainorganoidsonchipadvanceschallengesandperspectivesforpreclinicalapplications AT rontardjessica humanbrainorganoidsonchipadvanceschallengesandperspectivesforpreclinicalapplications AT honeggerthibault humanbrainorganoidsonchipadvanceschallengesandperspectivesforpreclinicalapplications |